BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast ca...
Q2 2026
Mar 10, 2026
Q1 2026
Dec 11, 2025
FY 2025
Oct 16, 2025
Q4 2025
Q3 2025
Jun 16, 2025